2017-10-17T11:49:40-05:00 2016-12-31 521853933 JONES MARESCA & MCQUADE PA 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2016-01-01 412161648 INNOVATIONS IN CANCER THERAPY INNO 2023671164 2025 M STREET NW NO 800 WASHINGTON DC 20036 CAMERON CURTIS CURRENT EXECUTIVE DIRECTOR 2023671164 2017-10-16 1 DAVID JONES P01361002 4108840220 64.88.174.3 2017-10-16 13:58:06 ED P 6B3294020F42B9E559A00BBAECB87153F921F36C D290BDE8761DF011E70E2880CE141E1E230E14A5 2016 2021-01-29 14:40:06Z WORLD CONFERENCE FOR INTERVENTIONAL ONCOLOGY CAMERON CURTIS 2025 M STREET NW NO 800 WASHINGTON DC 20036 1039034 0 X WWW.IO-CENTRAL.ORG X 2005 MA TO ESTABLISH, NURTURE, AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 9 9 0 9 0 0 0 50000 996400 989034 0 0 0 0 996400 1039034 0 35223 0 0 0 0 0 0 0 1079463 955258 1079463 990481 -83063 48553 140331 144363 62500 17979 77831 126384 TO ESTABLISH, NURTURE, AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 0 0 ANNUAL MEETING - ICT HOLDS AN ANNUAL MULTIDISCIPLINARY SCIENTIFIC MEETING, WITH EXHIBITS ON INTERVENTIONAL ONCOLOGY ISSUES. THE MEETING PRESENTS CURRENT INFORMATION ON RESEARCH, NEW PRODUCTS, AND NEW TECHNIQUES IN THE INTERVENTIONAL ONCOLOGY FIELD. 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 29 0 1 0 0 0 0 0 0 0 X 9 9 0 1 0 0 0 0 0 1 1 0 0 1 1 0 0 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671164 2025 M STREET NW NO 800 WASHINGTON DC 20036 X JEFF H GESCHWIND MD CHAIR 2.00 X X 0 0 0 STEPHEN SOLOMON MD CHAIR ELECT 1.00 X X 0 0 0 RICCARDO LENCIONI MD PHD IMMEDIATE PAST CHAIR 1.00 X 0 0 0 ALBAN DENYS MD BOARD MEMBER 1.00 X 0 0 0 AFSHIN GANGI MD BOARD MEMBER 1.00 X 0 0 0 NAHUM GOLDBERG MD BOARD MEMBER 1.00 X 0 0 0 KEVIN KIM MD BOARD MEMBER 1.00 X 0 0 0 RIAD SALEM MD MBA BOARD MEMBER 1.00 X 0 0 0 WILLIAM RILLING BOARD MEMBER 1.00 X 0 0 0 JEANNE MENDELSON EXECUTIVE DIRECTOR THROUGH 6/2016 10.00 X 0 0 0 CAMERON CURTIS EXECUTIVE DIRECTOR BEGINNING 6/2016 10.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2025 M STREET NW STE 800 WASHINGTON DC 20036 MANAGEMENT (INCL. ED COMP.) 340478 1 50000 50000 ANNUAL MEETING 900099 930994 930994 ONLINE LEARNING 900099 32861 32861 CORPORATE PARTNER PROG 900099 20000 20000 PUBLICATIONS 900099 5179 5179 989034 1039034 989034 0 0 35223 363888 4000 24279 28519 5008 29312 497742 1530 MISCELLANEOUS 980 990481 70539 28276 50000 19316 8690 50476 57397 140331 144363 6770 17979 55730 62500 17979 X 77831 77082 49302 77831 126384 140331 144363 48553 0 X X 1 X 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: ICT BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 CONTRIBUTION RECEIVED FROM U.K. DONOR 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 TRAVEL SCHOLARSHIPS TO THE WCIO CONFERENCE 52 35223 PART I, LINE 2: INNOVATIONS IN CANCER THERAPY AND THE WCIO CONFERENCE INVESTS IN THE SUCCESS OF THE INTERVENTIONAL ONCOLOGY (IO) FIELD BY OFFERING FUTURE IO PROFESSIONALS THE OPPORTUNITY TO ATTEND AND ENGAGE IN WCIO ANNUAL CONFERENCES THROUGH THE WCIO 2016 ANNUAL MEETING SCHOLARSHIP. THE SCHOLARSHIP IS OPEN TO ALL INTERVENTIONAL RADIOLOGY FELLOWS, DIAGNOSTIC RADIOLOGY RESIDENTS AND POST-GRADUATE MEDICAL STUDENTS WITHIN THE UNITED STATES. AN APPLICANT MUST BE IN THEIR ACGME INTERVENTIONAL RADIOLOGY FELLOWSHIP OR ACGME DIAGNOSTIC RADIOLOGY RESIDENCY AT THE TIME OF APPLICATION, OR BE A POST-GRADUATE MEDICAL STUDENT WITHIN THE IO FIELD. MINIMAL MONITORING IS REQUIRED. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE SHALL BE COMPRISED OF THE ELECTIVE OFFICERS OF THE ORGANIZATION, THE CHAIR, VICE-CHAIR AND PAST-CHAIR. THE COMMITTEE SHALL MEET REGULARLY AS OUTLINED IN THE BOARD POLICY. THE EXECUTIVE COMMITTEE SHALL ACT FOR THE BOARD OF DIRECTORS IN THE INTERIM BETWEEN MEETINGS OF THE BOARD BY A TWO-THIRDS VOTE. ALL DIRECTORS SHALL BE SENT ELECTRONIC NOTICE OF AN EXECUTIVE COMMITTEE VOTE WITHIN FIVE (5) BUSINESS DAYS OF SUCH VOTE, ALONG WITH THE OPPORTUNITY TO NOTIFY THE CHIEF EXECUTIVE OFFICER ELECTRONICALLY WITHIN A DATE SPECIFIED IN SUCH NOTICE (SAID DATE NOT TO BE LESS THAN FIVE (5) BUSINESS DAYS AFTER THE DATE OF SUCH NOTICE) IF THEY WISH THE EXECUTIVE COMMITTEE VOTE TO BE SUBJECT TO RATIFICATION BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 3 THE ORGANIZATION HAS ENTERED INTO A MANAGEMENT CONTRACT WITH SMITHBUCKLIN CORPORATION. UNDER THE TERMS OF THIS CONTRACT, ICT MAKES PAYMENTS TO SMITHBUCKLIN WHICH COVER STAFF SALARIES AND OTHER OVERHEAD EXPENSES. SMITHBUCKLIN'S PERFORMANCE UNDER THIS AGREEMENT IS MONITORED BY THE BOARD OF ICT. THE FEES INCURRED BY ICT DURING THE YEAR ENDED DECEMBER 31, 2016 WERE $363,888 WHICH WERE BROKEN DOWN AS FOLLOWS: EXECUTIVE DIRECTOR/MANAGEMENT AND HEADQUARTERS $50,000, MEMBERSHIP AND OPERATIONS - $44,973, FINANCIAL MANAGEMENT AND ACCOUNTING SERVICES - $15,000, EVENT SERVICES - $52,800, MARKETING AND COMMUNICATIONS SERVICES - $79,845, INFORMATION TECHNOLOGY SERVICES - $43,788, EDUCATION AND LEARNING SERVICES - $64,045, PROJECT PRINTING AND SUPPORT - $10,802 AND PROMOTIONAL PRODUCTS AND SUPPORT $2,635. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE STAFF OF THE MANAGEMENT COMPANY, INCLUDING THE EXECUTIVE DIRECTOR, AND A COPY IS PROVIDED TO THE ENTIRE BOARD PRIOR TO FILING. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED ITS OVERSIGHT PROCESS OR SELECTION PROCESS OF AN INDEPENDENT ACCOUNTANT DURING THE TAX YEAR.